Title | International Clinical Psychopharmacology |
Abbreviation | Int. Clin. Psychopharmacol. |
Publication Type | Journal |
Subject Area, Categories, Scope | Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2) |
h-index | 98 |
Overall Rank/Ranking | 8588 |
SCImago Journal Rank (SJR) | 0.621 |
Impact Score | 2.10 |
Publisher | Lippincott Williams and Wilkins Ltd. |
Country | United States |
ISSN | 02681315, 14735857 |
Best Quartile | Q2 |
Coverage History | 1986-2023 |
International Clinical Psychopharmacology provides an essential link between research and clinical practice throughout psychopharmacology. It reports on studies in human subjects, both healthy volunteers and patients, which relate the effects of drugs on psychological processes.
A major objective of the journal is to publish fully refereed papers which throw light on the ways in which the study of psychotropic drugs can increase our understanding of psychopharmacology. To this end the journal publishes results of early Phase I and II studies, as well as those of controlled clinical trials of psychotropic drugs in Phase II and IV.
International Clinical Psychopharmacology is a journal covering the technologies/fields/categories related to Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2). It is published by Lippincott Williams and Wilkins Ltd.. The overall rank of International Clinical Psychopharmacology is 8588. According to SCImago Journal Rank (SJR), this journal is ranked 0.621. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 98. The best quartile for this journal is Q2.
The ISSN of International Clinical Psychopharmacology journal is 02681315, 14735857. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. International Clinical Psychopharmacology is cited by a total of 326 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of International Clinical Psychopharmacology is 2.10, which is computed in 2024 as per its definition. International Clinical Psychopharmacology IF is decreased by a factor of 0.58 and approximate percentage change is -21.64% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of International Clinical Psychopharmacology is 2.10. If the same downward trend persists, Impact IF may fall in 2024 as well.
Year | Impact IF |
---|---|
2023/2024 | Coming Soon |
2023 | 2.10 |
2022 | 2.68 |
2021 | 2.02 |
2020 | 1.44 |
2019 | 1.91 |
2018 | 1.90 |
2017 | 2.53 |
2016 | 3.49 |
2015 | 3.13 |
2014 | 2.96 |
International Clinical Psychopharmacology has an h-index of 98. It means 98 articles of this journal have more than 98 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of International Clinical Psychopharmacology is 02681315, 14735857. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of International Clinical Psychopharmacology is 8588. According to SCImago Journal Rank (SJR), this journal is ranked 0.621. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Year | SJR |
---|---|
2023/2024 | Coming Soon |
2023 | 0.621 |
2022 | 0.672 |
2021 | 0.521 |
2020 | 0.559 |
2019 | 0.799 |
2018 | 0.834 |
2017 | 1.086 |
2016 | 1.097 |
2015 | 1.048 |
2014 | 1.003 |
Year | Ranking |
---|---|
2023/2024 | Coming Soon |
2023 | 8588 |
2022 | 7483 |
2021 | 9606 |
2020 | 9016 |
2019 | 5925 |
2018 | 5584 |
2017 | 3901 |
2016 | 3829 |
2015 | 4151 |
2014 | 4322 |
International Clinical Psychopharmacology is published by Lippincott Williams and Wilkins Ltd.. It's publishing house is located in United States. Coverage history of this journal is as following: 1986-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of International Clinical Psychopharmacology is Int. Clin. Psychopharmacol.. This abbreviation ('Int. Clin. Psychopharmacol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
International Clinical Psychopharmacology latest impact IF is 2.10. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 3.49 (2016) and 1.44 (2020), respectively, in the last 10 years. Moreover, its average IS is 2.42 in the previous 10 years.
The International Clinical Psychopharmacology has an SJR (SCImago Journal Rank) of 0.621, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.097 in 2016 and the lowest being 0.521 in 2021. Furthermore, the average SJR of the International Clinical Psychopharmacology over the previous 10-year period stands at 2.42.
The latest h-index of the International Clinical Psychopharmacology is 98.
The International Clinical Psychopharmacology is published by the Lippincott Williams and Wilkins Ltd., with its country of publication being the United States.
The International Clinical Psychopharmacology is currently ranked 8588 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 3829 in 2016 and its lowest position of 9606 in 2021.
The standard ISO4 abbreviation for the International Clinical Psychopharmacology is Int. Clin. Psychopharmacol..
International Clinical Psychopharmacology is classified as a journal that the Lippincott Williams and Wilkins Ltd. publishes.
The International Clinical Psychopharmacology encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The International Clinical Psychopharmacology is assigned the following International Standard Serial Numbers (ISSN): 02681315, 14735857.
The best quartile for the International Clinical Psychopharmacology is Q2 (2023).
The International Clinical Psychopharmacology coverage history can be summarized as follows: 1986-2023.
Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
---|---|---|---|---|---|
Zeitschrift fur Germanistische Linguistik | journal | 14988 | Walter de Gruyter GmbH | 16 | 0.40 |
Journal of Field Archaeology | journal | 5619 | Maney Publishing | 45 | 1.64 |
Clinical Medicine and Research | journal | 14722 | Marshfield Clinic | 62 | 1.02 |
Entrepreneurship Theory and Practice | journal | 220 | Wiley-Blackwell | 198 | 15.69 |
Archives of Phytopathology and Plant Protection | journal | 15268 | Taylor and Francis Ltd. | 33 | 1.39 |
International Journal of Applied Linguistics | journal | 6241 | Wiley-Blackwell Publishing Ltd | 53 | 1.91 |
European Journal of Education | journal | 4662 | Wiley-Blackwell Publishing Ltd | 59 | 3.64 |
Sex Education | journal | 7722 | Routledge | 45 | 2.66 |
Libyan Studies | journal | 19526 | Cambridge University Press | 9 | 0.30 |
Asian Textile Journal | trade journal | 27997 | G P S Kwatra | 11 | 0.03 |
Year | Impact Score (IS) |
---|---|
2024/2025 | Coming Soon |
2023 | 2.10 |
2022 | 2.68 |
2021 | 2.02 |
2020 | 1.44 |
2019 | 1.91 |
2018 | 1.90 |
2017 | 2.53 |
2016 | 3.49 |
2015 | 3.13 |
2014 | 2.96 |